Manipal Health IPO: Unpacking Value Beyond Price

Manipal Health’s Initial Public Offering (IPO) appears expensive, yet three hidden metrics reveal its underlying strength. The company expanded from 33 to 49 hospitals and increased licensed beds from 9,520 to 13,037 in two years.

Key Operational Metrics

• Network Expansion: From 33 to 49 hospitals
• Licensed Beds Added: From 9,520 to 13,037
• Annual Patients Treated: 7.63 million
• Occupancy Rate: 64.47%
• Average Length of Stay (ALOS): 2.78 days
• Average Revenue Per Occupied Bed (ARPOB): INR 68,938/day
• Cash Share in Payor Mix: 30.33% (lowest)
• Insurance/TPA Share in Payor Mix: 49.68% (highest)
• Negative Working-Capital Cycle: 13 days in FY2026

Manipal’s restated consolidated figures for FY2026 show strong growth. Revenue increased by approximately 29.4% and profit by 31.1% between FY2024 and FY2026, indicating efficient asset utilization alongside new capacity.

Efficiency and Throughput

Manipal’s occupancy rate stands at 64.47%, the lowest among its peers. This is managed strategically, maintaining headroom and adding new beds only when occupancy nears 70%.

The average length of stay (ALOS) shows a clear efficiency edge at 2.78 days, significantly lower than competitors. This allows for higher patient throughput and strong inpatient volume growth, even with lower occupancy rates.

Revenue Streams and Network Reach

The average revenue per occupied bed (ARPOB) is INR 68,938/day, placing Manipal in the mid-tier. This figure saw an 11.7% growth from FY2024 to FY2026, driven by a richer case mix.

Manipal boasts the largest licensed bed base with 13,037 beds and a total of 49 hospitals. It holds leadership positions in multiple states and three metro markets, including Bengaluru, Kolkata, and Pune.

Payor and Specialty Mix

The company’s payor mix shows the lowest cash share at 30.33% and the highest insurance/TPA share at 49.68%. Despite a lower cash mix, Manipal maintains a negative working-capital cycle of 13 days in FY2026, indicating strong collection efficiency.

Manipal’s specialty profile is balanced, with cardiac and orthopedics as major contributors. This diversified approach avoids reliance on a single high-value franchise.

Overall, Manipal Health’s operational metrics, including network expansion and efficient patient throughput, present a stronger underlying value than its initial IPO valuation might suggest.